Page 1 of Clinical Trials for "Encephalitis, Tick-Borne", 30 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Last Updated: March 20, 2012
Condition(s): Tick-Borne Encephalitis; Encephalitis, Tick-Borne; Tick-Borne Disease; Glycoprotein E, Flavivirus; NSI Protein, Flavivirus
2
Active, not recruiting
Tick-Borne Encephalitis (TBE) Seropersistence After First Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)
Last Updated: February 18, 2011
Condition(s): Encephalitis, Tick-Borne
3
Completed
TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)
Last Updated: January 12, 2009
Condition(s): Encephalitis, Tick-Borne
4
Completed
An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE
Last Updated: December 7, 2011
Condition(s): Tick Borne Encephalitis (TBE)
5
Completed
Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children
Last Updated: August 2, 2010
Condition(s): Encephalitis, Tick-Borne
6
Completed
TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)
Last Updated: December 16, 2010
Condition(s): Encephalitis, Tick-Borne
7
Completed
Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults
Last Updated: January 18, 2008
Condition(s): Tick-Borne Encephalitis
8
Active, not recruiting
Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules
Last Updated: April 19, 2012
Condition(s): Tick Borne Encephalitis
9
Completed
Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children
Last Updated: January 23, 2008
Condition(s): Encephalitis, Tick-Borne
10
Completed
Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)
Last Updated: October 18, 2006
Condition(s): Encephalitis, Tick-Borne
11
Completed
Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years
Last Updated: June 12, 2006
Condition(s): Encephalitis, Tick-Borne
12
Completed
Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years
Last Updated: October 19, 2006
Condition(s): Encephalitis, Tick-Borne
13
Completed
FSME IMMUN NEW Follow-Up to Study 208 in Volunteers Aged 16 to 66 Years
Last Updated: June 12, 2006
Condition(s): Encephalitis, Tick-Borne
14
Completed
Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years
Last Updated: April 22, 2008
Condition(s): Encephalitis, Tick-Borne
15
Completed
Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR
Last Updated: October 18, 2006
Condition(s): Encephalitis, Tick-Borne
16
Completed
Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children
Last Updated: March 14, 2008
Condition(s): Encephalitis, Tick-Borne
17
Completed
FSME IMMUN NEW Follow-Up to Study 199 in Children Aged 1 to 6 Years
Last Updated: June 12, 2006
Condition(s): Encephalitis, Tick-Borne
18
Completed
Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule
Last Updated: March 27, 2008
Condition(s): Encephalitis, Tick-Borne
19
Completed
FSME IMMUN NEW Follow-Up to Study 205 in Children Aged 6 to 16 Years
Last Updated: June 12, 2006
Condition(s): Encephalitis, Tick-Borne
20
Completed
Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults
Last Updated: March 12, 2007
Condition(s): Encephalitis, Tick-Borne

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?cond=%22Encephalitis%2C+Tick-Borne%22

Page 1 of Clinical Trials for "Encephalitis, Tick-Borne", 30 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About